Downstream Processing Featured Articles
-
Roche Receives FDA Clearance For Herpes Simplex Virus Type 1 And 2 Tests
9/4/2012
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection.
-
Studies Put Kibosh On Statins For Breast Cancer Prevention
12/10/2012
New data from the Women’s Health Initiative dash cold water on the idea that statin therapy reduces breast cancer risk.The updated WHI findings showed no association between prior statin use and breast cancer risk in nearly 155,000 postmenopausal study participants followed prospectively for an average of 10.8 years.
-
Researchers Develop Method To Grow Artificial Tissues With Embedded Nanoscale sensors
8/26/2012
A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.
-
Tiny Capsule Effectively Kills Cancer Cells
2/6/2013
A tiny capsule invented at a UCLA lab could go a long way toward improving cancer treatment.
-
Dr. Brad Vince Of Vince & Associates Clinical Research Announces Award Of Nearly $10M Contract From The National Institute On Drug Abuse
9/19/2012
Vince & Associates Clinical Research announced it has been awarded a contract with the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medication in humans.
-
Bionengineers Introduce "Bi-Fi" — The Biological Internet
9/26/2012
If you were a bacterium, the virus M13 might seem innocuous enough. It insinuates more than it invades, setting up shop like a freeloading houseguest, not a killer. By Andrew Myers
-
NIH-Supported Study Shows How Immune Cells Change Wiring Of The Developing Mouse Brain
5/23/2012
Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development.
-
3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products
5/4/2012
3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules. The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.
-
Refine Technology And Gallus BioPharmaceuticals To Collaborate On Continuous BioManufacturing
1/22/2013
Refine Technology, LLC (Refine), the developer and worldwide supplier to the biotech industry of the ATF™ System, a best-in-class cell retention device, and Gallus BioPharmaceuticals, LLC (Gallus), the industry leading contract bulk biopharmaceuticals manufacturer, today announced a collaboration to optimize continuous cell culture processes.
-
Rockland Immunochemicals Acquires TrueBlot Product Line
12/13/2012
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, recently announced the acquisition of the TrueBlot IP/Western blot product line from eBioscience, Inc., an Affymetrix company.